B. Metzler seel. Sohn & Co. AG Acquires 25,418 Shares of HealthEquity, Inc. $HQY

B. Metzler seel. Sohn & Co. AG lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 29.7% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 111,108 shares of the company's stock after purchasing an additional 25,418 shares during the period. B. Metzler seel. Sohn & Co. AG owned 0.13% of HealthEquity worth $10,035,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Acorn Wealth Advisors LLC acquired a new position in HealthEquity during the 2nd quarter worth about $228,000. Two Sigma Securities LLC bought a new position in shares of HealthEquity in the second quarter worth about $1,022,000. Hsbc Holdings PLC raised its stake in shares of HealthEquity by 54.8% in the second quarter. Hsbc Holdings PLC now owns 43,615 shares of the company's stock worth $3,917,000 after acquiring an additional 15,434 shares during the last quarter. Bridger Management LLC acquired a new position in shares of HealthEquity during the second quarter worth approximately $4,662,000. Finally, Grandeur Peak Global Advisors LLC acquired a new position in shares of HealthEquity during the second quarter worth approximately $440,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 2,354 shares of the business's stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the transaction, the executive vice president owned 52,244 shares of the company's stock, valued at $4,963,180. The trade was a 4.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian T. Dillon sold 7,632 shares of the business's stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares of the company's stock, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,456 shares of company stock valued at $1,256,664 in the last ninety days. Insiders own 1.60% of the company's stock.

HealthEquity Stock Up 1.6%

NASDAQ:HQY opened at $98.54 on Thursday. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62. The stock's fifty day simple moving average is $98.91 and its 200-day simple moving average is $88.38. The firm has a market capitalization of $8.15 billion, a P/E ratio of 35.57, a P/E/G ratio of 1.53 and a beta of 0.22.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.05. The firm had revenue of $350.73 million for the quarter, compared to analysts' expectations of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The company's revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities research analysts expect that HealthEquity, Inc. will post 3.93 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on HQY shares. Weiss Ratings upgraded shares of HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a research report on Friday, June 5th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Saturday, August 22nd. Barrington Research reissued an "outperform" rating and issued a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd. Royal Bank Of Canada boosted their target price on HealthEquity from $100.00 to $108.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 3rd. Finally, KeyCorp reaffirmed an "overweight" rating on shares of HealthEquity in a research note on Tuesday, May 26th. Ten equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $111.87.

HealthEquity Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source